Drug Co-Packaging Proposed Rule Could Hamper Some OTC Marketing

OTC drug packages with separate containers of a product's daytime and nighttime formulations could be mislabeled under US FDA’s proposed rule, as well as co-packaged products with little similarity in use, such as an oral analgesic sold in tandem with a topical pain relief product.